Overall, the company from Vevey reported revenue of CHF 22.6 billion in the first three months of the new year, as announced ...

Fears are growing in the EU that sanctions against Russia may expire in July. Options for frozen foreign exchange reserves ...

Following competitor Novartis, pharma giant Roche also announces massive investments in the United States. Swiss jobs and ...

The number of companies listed on the SIX Swiss Exchange is declining—due not only to structural changes but also partly due ...

Investing in oil, gold, or wheat follows different rules than trading stocks or bonds. «Finanz und Wirtschaft» explains the ...

Switzerland has been placed on a US list comprising fifteen countries aiming for a «quick resolution» in the ongoing tariff ...

At the capital markets day at the end of March, Kühne + Nagel revised its strategy named «Roadmap 26.» Previously, the focus ...

Roche slightly surpassed revenue expectations in the first three months. The company reaffirms its full-year guidance.

The pharmaceutical and diagnostics company slightly exceeded expectations in the first quarter, driven by its pharmaceutical ...

The ongoing trade conflict and increasing economic concerns weigh heavily on earnings expectations. Yet, forecasts for the US ...

A Swiss financial centre initiative demands strict climate protection regulations for banks and insurers. UBS, Zurich ...

The Fed’s interest rate pause, closed capital markets, the tariff storm, and mass layoffs at the U.S. FDA create a ...